FDA Biologics (BLA & Biosimilars)Original article
OTAT Town Hall: Clinical Development of Gene Therapy Products for Rare Diseases - 02/07/2023
ConferenceNeutral
AI Analysis
Summary
The FDA's CBER Office of Tissues and Advanced Therapies is hosting a virtual town hall on February 7, 2023 to discuss clinical development of gene therapy products for rare diseases (excluding hematology/oncology).
Importance:2/10
Sentiment:
0.00
gene therapyrare diseasesFDA guidanceCBEROTAT
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 15, 2026 4:30 PM